Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx 1, an FDA-cleared digital pathology ...
In the most traditional definition of return-on-investment, Sam Terese, former CEO and president of Alverno Laboratories, would say that his company isn’t experiencing a strict apples-to-apples ...
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. The testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results